COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review

  1. Aline Pereira da Rocha
  2. Álvaro Nagib Atallah
  3. Ana Carolina Pereira Nunes Pinto
  4. César Ramos Rocha-Filho
  5. Keilla Martins Milby
  6. Vinicius Tassoni Civile
  7. Nelson Carvas Junior
  8. Felipe Sebastião de Assis Reis
  9. Laura Jantsch Ferla
  10. Gabriel Sodré Ramalho
  11. Giulia Fernandes Moça Trevisani
  12. Maria Eduarda dos Santos Puga
  13. Virgínia Fernandes Moça Trevisani

Reviewed by

Read the full article

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1590/1516-3180.2020.0421.r2.10092020
  2. ScreenIT

    SciScore for 10.1101/2020.05.01.20087494: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    Design: We will perform a rapid living systematic review methodology following the recommendations proposed by the Cochrane Collaboration Handbook (7).
    Cochrane Collaboration Handbook
    suggested: None
    Eligibility criteria: Data sources and searches: We will search PubMed, Embase, Cochrane Central Register of Controlled
    Embase
    suggested: (EMBASE, RRID:SCR_001650)
    The search strategy in Medline via Pubmed is shown in Table 1.
    Medline
    suggested: (MEDLINE, RRID:SCR_002185)
    Pubmed
    suggested: (PubMed, RRID:SCR_004846)
    Assessment of methodological quality in included studies and quality of the body of evidence: We will use Risk of Bias tool (7) as recommended by Cochrane Collaboration to perform the critical appraisal of included studies; for observational studies, we will use Newcastle Ottawa Scale (9).
    Cochrane Collaboration
    suggested: None
    Data Analysis: We will perform analyses according to the recommendations of Cochrane, and the Cochrane Prognosis Methods Group.
    Cochrane
    suggested: (Cochrane Library, RRID:SCR_013000)
    Cochrane Prognosis
    suggested: None
    For continuous outcomes, Egger’s test will be used to detect possible small study bias as recommended in Cochrane Handbook for Systematic Reviews of Interventions.
    Cochrane Handbook
    suggested: None

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a protocol registration statement.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2020.05.01.20087494v1 on medRxiv